Crohn's Disease Clinical Trials

Showing 321-340 of 1,088 trials

Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

NCT03998488

A double-blind, randomized, placebo-controlled clinical trial examining the efficacy and safety of Fecal Microbiota Transplantation (FMT) and high fiber supplementation in patients with active mild to moderate Ulcerative Colitis (UC). All enrolled subjects will provide serological, stool and mucosal specimen at each clinic visit to help further define the alterations in microbial profiles and immune cell function in response to psyllium fiber after FMT treatment.

Ulcerative ColitisInflammatory Bowel Diseases

Weill Medical College of Cornell University27 participantsStarted Jan 2020

New York, New York, United States

RECRUITING

Early Inflammatory Bowel Disease Progression

NCT06756100

The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.

Inflammatory Bowel DiseasesCrohn Disease (CD)Ulcerative Colitis (UC)

Pontificia Universidad Catolica de Chile140 participantsStarted Jul 2023

Santiago, Chile

Not Yet Recruiting

CRP /Albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients

NCT06750315

This study aimed to assess the clinical utility of the NLR (neutrophil lymphocyte ratio) and CRP Albumin ratio in predicting activity of IBD Patients in assiut university

Inflammatory Bowel Disease (IBD)

Assiut University35 participantsStarted Jan 2025

Asyut, Egypt • Egypt, Assiut, Egypt

Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

Early Inflammatory Bowel Disease Progression

CRP /Albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients

Related Searches

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

Evaluation of the Efficacy and Safety of Endoscopic Dilatation and Biological Therapy in Intestinal Stenosis Due to CD

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

Individual Treatment of Ustekinumab in Perianal Fistulizing Crohn's Disease

Analysis of Intestinal Defensin Expression in Acute GVHD

A Dietary Intervention Study on the Microbiome in Crohn's Disease Patients

Service Development of POCUS in the IBD Clinic

Development and Validation of a New Paediatric Inflammatory Bowel Disease NUTrition Risk Score (PIBD-NUTS)

Effects of Vaping on Post-operative Recurrence of Crohn's Disease

Autophagy in Paediatric Crohn's Disease

Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease

Remote Monitoring of Patients With an Inflammatory Bowel Disease Under no or Maintenance Therapy

The CROCO Study: CROhn's Disease COhort Study

Inflammatory Bowel Disease(IBD), Treatment Response

InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease

Endoscopically Placed Lumen-Apposing Metal Stents for the Treatment of Symptomatic Intestinal Strictures in Individuals With Inflammatory Bowel Disease

Markers of Oxidative Stress in Inflammatory Bowel Diseases: Risk Factors and Implications for a Dietetic Approach